Clinical Trials Logo

Dysfunctional RVOT Conduit clinical trials

View clinical trials related to Dysfunctional RVOT Conduit.

Filter by:
  • None
  • Page 1

NCT ID: NCT04860765 Recruiting - Clinical trials for Pulmonary Valve Insufficiency

COMPASSION S3 Post-Approval Study

Start date: April 13, 2021
Phase:
Study type: Observational

This study will monitor device performance and outcomes of the SAPIEN 3 Transcatheter Heart Valve (THV) System in subjects with a dysfunctional right ventricular outflow tract (RVOT) conduit or previously implanted surgical valve in the pulmonic position with a clinical indication for intervention.

NCT ID: NCT02744677 Recruiting - Clinical trials for Pulmonary Valve Insufficiency

COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction

Start date: July 5, 2016
Phase: N/A
Study type: Interventional

This study will demonstrate the safety and effectiveness of the Edwards Lifesciences SAPIEN 3/SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve (THV) Systems in subjects with a dysfunctional right ventricular outflow tract (RVOT) conduit or previously implanted valve in the pulmonic position with a clinical indication for intervention.

NCT ID: NCT00676689 Completed - Clinical trials for Pulmonary Regurgitation

COMPASSION - COngenital Multicenter Trial of Pulmonic VAlve Regurgitation Studying the SAPIEN InterventIONal THV

Start date: April 8, 2008
Phase: N/A
Study type: Interventional

To assess the safety and effectiveness of pulmonic THV implantation in subjects with dysfunctional RVOT conduit requiring treatment for moderate or severe pulmonary regurgitation (≥3+ pulmonary regurgitation) and/or RVOT conduit obstruction (mean gradient of >=35mmHg) by TTE.